These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 20360257

  • 1. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C, Pedersen TX, Gordts PL, Roebroek AJ, Dahlbäck B, Nielsen LB.
    Circ Res; 2010 May 28; 106(10):1624-34. PubMed ID: 20360257
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I.
    Arterioscler Thromb Vasc Biol; 2005 Aug 28; 25(8):1704-10. PubMed ID: 15905467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
    Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1914-20. PubMed ID: 12933536
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?
    Dahlbäck B, Nielsen LB.
    Cell Mol Life Sci; 2009 Feb 01; 66(4):559-64. PubMed ID: 19153651
    [Abstract] [Full Text] [Related]

  • 10. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Nov 15; 98(10):2259-67. PubMed ID: 8941642
    [Abstract] [Full Text] [Related]

  • 11. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R.
    Arterioscler Thromb Vasc Biol; 2008 Jul 15; 28(7):1277-82. PubMed ID: 18421000
    [Abstract] [Full Text] [Related]

  • 12. Microdispersed Oxidized Cellulose as a novel potential substance with hypolipidemic properties.
    Jamborova G, Pospisilova N, Semecky V, Hyspler R, Ticha A, Pospechova K, Solichova D, Maxová M, Briestensky J, Real KJ, Nachtigal P.
    Nutrition; 2008 Jul 15; 24(11-12):1174-81. PubMed ID: 18640007
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 14. Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice.
    Persson L, Borén J, Robertson AK, Wallenius V, Hansson GK, Pekna M.
    Arterioscler Thromb Vasc Biol; 2004 Jun 26; 24(6):1062-7. PubMed ID: 15059809
    [Abstract] [Full Text] [Related]

  • 15. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biol Chem; 2005 May 26; 386(5):441-52. PubMed ID: 15927888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V.
    Life Sci; 2008 Mar 26; 82(13-14):708-17. PubMed ID: 18289605
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA, Papachristou DJ, Kotsikogianni I, Giopanou I, Kypreos KE.
    FEBS J; 2011 Sep 26; 278(17):3119-29. PubMed ID: 21740524
    [Abstract] [Full Text] [Related]

  • 20. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.